Since placental HtrA4 is secreted into the maternal blood, elevated circulating HtrA4 may adversely impact the maternal vasculature and contribute to systemic endothelial dysfunction, which is often observed in early-onset preeclampsia. The gene discussed is HTRA4; the disease is preeclampsia.